The global tyrosine protein kinase Fyn market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Tyrosine-protein kinase Fyn is a non-receptor tyrosine. It plays an important role in the learning and memory of both animal models and human beings and is also responsible for other psychological disorders or mental problems such as schizophrenia, bipolar disorder, and depression, among others. The major factor driving the growth of the market is the increasing prevalence of breast cncer across the globe.
According to the World Health Organization (WHO), breast cancer is the most common cancer globally accounting for 12% of all new annual cancer cases globally in 2021. Additionally, as per US Breast Cancer Statistics, about 1 in 8 US women or 13% will develop invasive breast cancer throughout their lifetime. Further, as per the same source, an estimated 287,850 new cases of invasive breast cancer are anticipated to be diagnosed in women in the US along with 51,400 new cases of non-invasive breast cancer in 2022.
To Request a Sample of our Report on Tyrosine Protein Kinase Fyn Market: https://www.omrglobal.com/request-sample/tyrosine-protein-kinase-fyn-market
Apart from this, tyrosine protein kinase Fyn drugs are used for treating metastatic and non-metastatic hormone receptor-positive or human epidermal growth factor receptor-positive. Additionally, it also used to treat patients with metastatic, hormone-receptor-positive breast cancer. Hence, the increasing prevalence of breast cancer is driving the demand for tyrosine protein kinase Fyn for treatment which in turn is driving the growth of the market. Moreover, North America is anticipated to hold a prominent share in the market due to the presence of disease such as cancer, Alzheimer, among others. Some major players in the market include Merck KGaA, AstraZeneca Plc, and Bristol-Myers Squibb Co., among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Merck KGaA, AstraZeneca Plc, and Bristol-Myers Squibb Co., among others.
(Get 15% Discount on Buying this Report)
A full Report of Tyrosine Protein Kinase Fyn Market is Available @ https://www.omrglobal.com/industry-reports/tyrosine-protein-kinase-fyn-market
Global Tyrosine Protein Kinase Fyn Market Report by Segment
By Type
- Dasatinib
- Masitinib
- VAL-201
- Others
By Application
- Alzheimer’s Disease
- Alcohol Addiction
- Breast Cancer
- Cancer Pain
- Others
Global Tyrosine Protein Kinase Fyn Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
